Skip to content
Logo.
The HBS Digital Initiative reshapes digital to create a world where technology advances and serves humanity. The DI manages this forum to highlight perspectives from the HBS student community.
Want to learn more about technology and organizations? digital.hbs.edu
Close and dismiss. Expand.
Technology and Operations Management

Technology and Operations Management

MBA Student Perspectives

  • Assignments
Search for:
  • Log In
  • Log In

    Lost your password?

FDA

Bioprinting: How the Manufacturing of Human Organs Will Disrupt Healthcare

Posted on November 13, 2018 by RJ

This short article describes how Organovo is using a novel technology called bioprinting to produce liver and kidney tissues that could help reshape the way drugs are tested and organs are transplanted in our days. It also discusses the challenges and potential effects on society.

FDA in the Age of Machine Learning: Big Data, Big Risks?

Posted on November 12, 2018 by Vinay Rathi

Advances in machine learning and artificial intelligence may now enable patients and providers to detects life-threatening illnesses earlier than ever. But much remains unknown about these rapidly evolving diagnostics. Can the FDA keep up while protecting public health in the era of big data?

Climate change in your medicine cabinet: How the FDA is working to secure the pharmaceutical supply chain.

Posted on November 15, 2017 by Samantha_Halpern

The US Food and Drug Administration (FDA) takes steps to protect against threats to the pharmaceutical supply chain posed by extreme weather events.

Can blockchain help solve the problem of counterfeit drugs?

Posted on November 14, 2017 by Michelle

Counterfeit drugs adversely impact both consumers and pharmaceutical companies. Can blockchain help solve this problem?

Climate Crisis or Global Health Crisis? Devastation in Puerto Rico reveals vulnerability of the pharmaceutical supply chain

Posted on November 13, 2017 by Ashley V

With its destructive power, Hurricane Maria revealed the fragility of the global pharmaceutical supply chain when it struck Puerto Rico, a major drug manufacturing hub, earlier this year. How can US regulatory bodies mitigate the impact climate change, and the resulting “super storms”, has on drug availability?

Evaluating New Drugs with Wearable Technology

Posted on November 18, 2016 by Tarran

Can wearables and electronic data capture (EDC) technologies improve clinical trials and accelerate new drug approval?

    A project of:
    At:
    • Assignments
    • Terms and Conditions / Privacy Policy
    • Community Guidelines
    • Contact Us